Drug class in one race
HDAC drugs for Multiple Myeloma
2 tracked HDAC drugs in the Multiple Myeloma race. The class explanation lives on the HDAC page; the full indication pipeline across every mechanism is on the Multiple Myeloma page.
1 approved / phase 41 Phase 1/2
Head-to-head evidence: Panobinostat vs Purinostat Mesylate